Study of 18F-FAPI PET/CT for breast cancer lymph node detection
Part of Cancer, Skin clinical trials.
This study tests a new kind of PET/CT scan that uses a tracer called 18F-FAPI to see if it can better detect cancer in the lymph nodes under the arm after you've already had chemotherapy or targeted therapy before surgery. If successful, this could help doctors plan more precise surgery and avoid removing unnecessary lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 80 years old.
- You have been diagnosed with invasive breast cancer that has not spread to distant organs (stage T1-4N0-1M0).
- You have already completed standard chemotherapy or targeted therapy before surgery (neoadjuvant therapy).
- You are willing to undergo a special PET/CT scan that uses a radioactive tracer called 18F-FAPI.
- You have no other active cancers (except cured skin cancer, very early cervical cancer, or papillary thyroid cancer) within the last 5 years.
- Your blood counts and organ function (liver, kidney, blood clotting) are within a healthy range for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This study uses a special PET scan (68Ga FAPI) to check if lymph nodes under the arm still have cancer after you finish pre-surgery treatment. It helps doctors see how well the treatment worked before you have surgery.
This trial tests a special PET scan (F-FAPI PET) to image metastatic invasive lobular breast cancer. It aims to see if this scan gives a clearer picture than the standard PET scan, helping doctors track the cancer better.
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
This trial uses a special PET scan (68Ga-FAPi-46) to see how breast cancer interacts with nearby cells. It may help doctors understand your tumor better and guide treatment decisions, especially if you are planning surgery or chemotherapy before surgery.
This study tests a new type of PET scan that uses a special tracer called FAPI to find where cancer has spread in your body. It may help doctors see hidden tumors more clearly without needing extra treatments first.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.